Celox

BACKGROUND Uncontrolled hemorrhage is a well-recognized cause of mortality in trauma victims and the control of active hemorrhage… (More)

The aim of this study is to evaluate the effect of these new generation hemostatic agents on early-stage soft tissue healing of… (More)

Haemorrhage from severe pelvic fractures can be associated with significant mortality. Modern civilian trauma centres may manage… (More)

The use of Celox, a chitosan-based haemostatic agent, for the control of massive traumatic bleeding in patients arriving at a… (More)

BACKGROUND The purpose of this study was to evaluate the efficacy of zeolite- and chitosan-based local hemostatic agents for the… (More)

The purpose of this study was to compare the effectiveness of 2 hemostatic agents, chitosan-based Celox and the biopolymeric… (More)

BACKGROUND Hemorrhage is the second leading cause of death in civilian trauma and the leading cause of preventable death in… (More)

Celox (MedTrade Products Ltd, Cheshire, UK) is a proprietary preparation of chitosan, indicated for moderate to severe hemorrhage… (More)

BACKGROUND Major improvements have been made in the development of novel dressings with hemostatic properties to control heavy… (More)

BACKGROUND The use of mineral (clay) or biologic (chitosan) materials has improved the efficacy of dressings used in the bleeding… (More)